Shiraishi T - Search Results

1

Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells.

Watanabe M, Yoneda M, Morohashi A, Hori Y, Okamoto D, Sato A, Kurioka D, Nittami T, Hirokawa Y, Shiraishi T, Kawai K, Kasai H, Totsuka Y. Watanabe M, et al. Among authors: shiraishi t. Int J Mol Sci. 2013 Jul 25;14(8):15546-60. doi: 10.3390/ijms140815546. Int J Mol Sci. 2013. PMID: 23892599 Free PMC article.

2

Malignant phyllodes tumor of the prostate: retrospective review of specimens obtained by sequential transurethral resection.

Watanabe M, Yamada Y, Kato H, Imai H, Nakano H, Araki T, Shiraishi T. Watanabe M, et al. Among authors: shiraishi t. Pathol Int. 2002 Dec;52(12):777-83. doi: 10.1046/j.1440-1827.2002.01417.x. Pathol Int. 2002. PMID: 12588447

3

[Anatomy and physiology of the prostate].

Nakano H, Watanabe M, Shiraishi T. Nakano H, et al. Among authors: shiraishi t. Nihon Rinsho. 2002 Dec;60 Suppl 11:7-11. Nihon Rinsho. 2002. PMID: 12599536 Review. Japanese. No abstract available.

4

Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer.

Yamada Y, Watanabe M, Yamanaka M, Hirokawa Y, Suzuki H, Takagi A, Matsuzaki T, Sugimura Y, Yatani R, Shiraishi T. Yamada Y, et al. Among authors: shiraishi t. Cancer Sci. 2003 Jun;94(6):536-9. doi: 10.1111/j.1349-7006.2003.tb01479.x. Cancer Sci. 2003. PMID: 12824880 Free article.

5

The 3'UTR of stem cell factor suppresses protein expression from a cotransfected vector.

Hirokawa YS, Watanabe M, Shiraishi T. Hirokawa YS, et al. Among authors: shiraishi t. Biochem Biophys Res Commun. 2003 Sep 19;309(2):469-74. doi: 10.1016/j.bbrc.2003.08.025. Biochem Biophys Res Commun. 2003. PMID: 12951073

6

Intravascular large B-cell lymphoma presenting with mass lesions in the central nervous system: a report of five cases.

Imai H, Kajimoto K, Taniwaki M, Miura I, Hatta Y, Hashizume Y, Watanabe M, Shiraishi T, Nakamura S. Imai H, et al. Among authors: shiraishi t. Pathol Int. 2004 Apr;54(4):231-6. doi: 10.1111/j.1440-1827.2004.01613.x. Pathol Int. 2004. PMID: 15028023

7

Identification of differentially methylated CpG islands in prostate cancer.

Yamada Y, Toyota M, Hirokawa Y, Suzuki H, Takagi A, Matsuzaki T, Sugimura Y, Yatani R, Shiraishi T, Watanabe M. Yamada Y, et al. Among authors: shiraishi t. Int J Cancer. 2004 Dec 10;112(5):840-5. doi: 10.1002/ijc.20335. Int J Cancer. 2004. PMID: 15386391 Free article.

8

[Polymorphisms of hormone-related genes and prostate cancer risk in Japan].

Watanabe M, Hirokawa Y, Shiraishi T. Watanabe M, et al. Among authors: shiraishi t. Nihon Rinsho. 2005 Feb;63(2):219-24. Nihon Rinsho. 2005. PMID: 15714969 Review. Japanese.

9

Knowledge of epigenetic influence for prostate cancer therapy.

Watanabe M, Takagi A, Matsuzaki T, Kami D, Toyota M, Hirokawa Y, Shiraishi T. Watanabe M, et al. Among authors: shiraishi t. Curr Cancer Drug Targets. 2006 Sep;6(6):533-51. doi: 10.2174/156800906778194568. Curr Cancer Drug Targets. 2006. PMID: 17017872 Review.

10

A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.

Shibahara T, Onishi T, Franco OE, Arima K, Nishikawa K, Yanagawa M, Hioki T, Watanabe M, Hirokawa Y, Shiraishi T, Sugimura Y. Shibahara T, et al. Among authors: shiraishi t. Anticancer Res. 2006 Sep-Oct;26(5A):3365-71. Anticancer Res. 2006. PMID: 17094454 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,592 results

Search Page